AN-9025
N/A
Report date: 2026/05/09 20:00:18
NME
Base Information
Drug NameAN-9025
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Adlai Nortye Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A